---
schema_version: "secwatch.filing_event.v1"
accession: "0001779128-24-000012"
form_type: "8-K"
ticker: "SRTA"
cik: "0001779128"
company_name: "Strata Critical Medical, Inc."
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T23:10:57.891299+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Blade Q4 revenue up 24.5% to $47.5M; guides for 2024 Adj. EBITDA profitability

## Summary
- Q4 revenue $47.5M (+24.5% YoY); full year revenue $225.2M (+54.1%).
- Net loss widened to $(33.9)M in Q4 from $(15.4)M; Adj. EBITDA improved to $(5.2)M from $(8.0)M.
- Full year 2023 Adj. EBITDA $(16.6)M; guides for 2024 Adj. EBITDA profitability and 2025 double-digit millions.
- Announced pending purchase of eight jet aircraft to support Medical growth; new organ placement service launched.
- Medical segment Adj. EBITDA positive $2.5M in Q4, up 57.8% YoY; Passenger Adj. EBITDA loss improved to $(2.6)M.

## SEC filing metadata
- accession: 0001779128-24-000012
- form_type: 8-K
- ticker: SRTA
- cik: 0001779128
- company_name: Strata Critical Medical, Inc.
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779128/000177912824000012/0001779128-24-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779128/000177912824000012/blde-20240312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001779128-24-000012
- JSON: https://secwatch.observer/filing/0001779128-24-000012.json
- Plain text: https://secwatch.observer/filing/0001779128-24-000012.txt

## Key facts
- Earnings Releases
  Strata Critical Medical, Inc. reported the fourth quarter ended December 31, 2023 results: revenue $47,478, net income $(33,941). Guidance initiated.
  - Period: the fourth quarter ended December 31, 2023
  - Revenue: $47,478
  - Net income: $(33,941)
  - Guidance: initiated
  - Result: reported results
  source text: 2023. GAAP FINANCIAL RESULTS (in thousands except percentages, unaudited) Three Months Ended December 31, Year Ended December 31, 2023 2022 % Change 2023 2022 % Change Revenue $ 47,478 $ 38,135 24.5 % $ 225,180 $ 146,120 54.1 % Cost of revenue 38,468 33,160 16.0 % 183,058 123,845 47.8 % Software development 988 1,622 (39.1) % 4,627 5,545 (16.6) % General and
  evidence_url: https://www.sec.gov/Archives/edgar/data/1779128/000177912824000012/0001779128-24-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.